Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 5Neoplasms 3Colorectal Neoplasms 3Adenoma 3Stomatitis 2Stomach Neoplasms 2Insulin Resistance 2Breast Neoplasms 2Vulvodynia 1Urologic Neoplasms 1Urolithiasis 1Thyroid Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Mobility Limitation 1Melanoma 1MRSA Colonization 1Lymphoma 1Leukemia 1Ilues 1Hypothyroidism 1Hydronephrosis 1Hematologic Diseases 1Head and Neck Neoplasms 1Fatigue 1Fasting 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 28Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Water × Clear all
NCT06155708 2025-01-22

Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome

McGill University

Phase NA Recruiting
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡